| Literature DB >> 30373220 |
Ji Wang1,2, Chenglin Yang3, Zhihang Yuan4,5, Jine Yi6, Jing Wu7.
Abstract
Although mTOR (the mammalian target of rapamycin) can regulate intracellular free Ca2+concentration in normal cultured podocytes, it remains elusive as to how mTORC2/AKT-mediated Ca2+participates in the process of T-2 toxin-induced apoptosis. The potential signaling responsible for intracellular Ca2+ concentration changes was investigated using immunoblot assays in an in vitro model of TM3 cell injury induced by T-2 toxin. Changes in Ca2+ were assessed using the Ca2+-sensitive fluorescent indictor dye Fura 2-AM. The cytotoxicity of TM3 cells was assessed with an MTT bioassay, and apoptosis was measured using Annexin V-FITC staining. Following T-2 toxin treatment, the growth of cells, phospho-mTORSer2481, phospho-mTORSer2448, and phospho-AktSer473 were significantly decreased in a time-dependent manner, whereas Ca2+ and apoptosis were increased. T-2 toxin-induced apoptosis was prevented by BAPTA-AM (a Ca2+chelator) and MHY1485 (an mTOR activator), and the application of mTOR activator MHY1485 also prevented the increase of intracellular free Ca2+concentration in TM3 cells. Our results strongly suggest that T-2 toxin exposure induces apoptosis in TM3 cells by inhibiting mTORC2/AKT to promote Ca2+ production.Entities:
Keywords: AKT; T-2 toxin; TM3 cell; apoptosis; calcium; mTOR
Mesh:
Substances:
Year: 2018 PMID: 30373220 PMCID: PMC6274855 DOI: 10.3390/ijms19113360
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1T-2 toxin decreases viability in TM3 cells. ** indicates p < 0.01 when compared with the untreated group. Each experiment was performed and repeated at least three times.
Figure 2T-2 toxin induces intrinsic apoptosis in TM3 cells. (A) Expression of cleaved-caspase-3 was analyzed by Western blotting. (B) Level of cleaved-caspase-3 was quantified by densitometry. (C) Apoptosis was analyzed by Annexin V/PI assays in TM3 cells. (D) Percentage of apoptotic cells treated by T-2 toxin. T-2 toxin induced apoptosis in a time-dependent manner. * indicates p < 0.05 and ** indicates p < 0.01 when compared with the untreated group. Each experiment was performed and repeated at least three times.
Figure 3Induction of Ca2+ is involved in T-2 toxin-mediated TM3 cell apoptosis. (A) Representative images of the fluorescence intensity of intracellular free Ca2+ measured with Fura-2/AM, images were captured at 200× magnification. (B) T-2 toxin induced an increase in the free Ca2+ intracellular concentration in a time-dependent manner. (C) BAPTA-AM pretreatment attenuated the increase of free Ca2+ intracellular concentration. (D) Expression of cleaved-caspase-3 was analyzed by Western blot assay. (E) Level of cleaved-caspase-3 was quantified by densitometry. (F) Apoptosis was analyzed by Annexin V/PI assays in TM3 cells. (G) Percentage of apoptotic cells treated with T-2 toxin and (or) BAPTA-AM. BAPTA-AM attenuated the increase of percentage of apoptotic cells caused by treatment with T-2 toxin. * indicates p < 0.05 and ** indicates p < 0.01 when compared with the control group. ## indicates p < 0.01 when the co-treated group is compared with the group only treatment with T-2 toxin. Each experiment was performed and repeated at least three times.
Figure 4Mammalian Target of Rapamycin/Serine/Threonine Protein Kinase (mTOR/Akt) pathway inhibition is related to T-2 toxin-mediated apoptosis. T-2 toxin reduced the relative expression of p-mTOR ser 2481 (A), p-mTOR ser 2448 (B), and p-AKT ser 473 (C). MHY1485 attenuated the T-2 toxin-caused suppression of phosphorylation of mTOR at ser 2481 (D), ser 2448 (E), and AKT at ser 473 (F). MHY1485 inhibited free Ca2+ intracellular concentration (G) and protected TM3 cells from apoptosis (H,I). * indicates p < 0.05 and ** indicates p < 0.01 when compared with the control group. ## indicated p < 0.01 when the co-treated group is compared with the group only treatment with T-2 toxin. Each experiment was performed and repeated at least three times.